The Art of Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing

PICK 50.39

+1.1%

Dec 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sun Tzu who wrote (3242)	5/5/2022 1:38:12 PM
From: Sun Tzu	Read Replies (2) of 10693

Royalty Pharma Plc Cl A (RPRX) reported 1st Quarter March 2022 earnings of $0.61 per share on revenue of $562.0 million. The consensus earnings estimate was $0.72 per share on revenue of $599.8 million. Revenue fell 1.9% compared to the same quarter a year ago. Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next